Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 15INDUSTRY 6OTHER_GOV 2UNKNOWN 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Lung Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Unresectable Non-small Cell Lung Cancer 1Tobacco Use Cessation 1Recurrence 1Rectal Diseases 1Pancreatic Cancer Liver Metastases 1Ovarian Neoplasms 1Ototoxicity 1Neoplasms, Second Primary 1Neoplasms by Site 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Intestinal Neoplasms 1Intestinal Diseases 1Hodgkin Disease 1Hearing Loss 1HER2 Positive Metastatic Breast Cancer 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1

Interventions

apatinib 4Etoposide 3surufatinib 2Topotecan 2Simvastatin 2Irinotecan 2Drug Therapy 2Carboplatin 2nintedanib 1camrelizumab 1anlotinib 1Tomography, X-Ray Computed 1Sunitinib 1Sorafenib 1Radiotherapy 1Paclitaxel 1PE regimen 1Lithium 1Immunotherapy 1Ifosfamide 1Gemcitabine 1EC regimen 1Cisplatin 1Breathing Exercises 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Small Cell Lung Carcinoma × Drug Therapy × Clear all
NCT07069270 2025-07-16

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

Fujian Cancer Hospital

Phase 2 Not yet recruiting
28 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06406660 2024-05-09

Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer

Henan Cancer Hospital

Phase NA Recruiting
20 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡